UnknownNot applicableNCT03941691
A Trial to Evaluate the Safety and Efficacy of a Fully Degradable Ventricular Septal Defect (VSD) Closure
Studying Rare congenital anomaly of ventricular septum
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Chinese Academy of Medical Sciences, Fuwai Hospital
- Principal Investigator
- Pan Xiangbin, MD, Ph.DChinese Academy of Medical Science, Fuwai Hospital
- Intervention
- Fully Absorbable VSD Occlusion System(device)
- Enrollment
- 108 enrolled
- Eligibility
- 1-60 years · All sexes
- Timeline
- 2019 – 2021
Study locations (4)
- Hefei high-tech cardiovascular hospital, Hefei, Anhui, China
- Structral Heart Disease Center, Fuwai Hospital, Beijing, Beijing Municipality, China
- The Second XIANGYA Hospital Of Central South University, Hunan, Changsha, China
- Children's Hospital Nanjing Medical University, Nanjing, Jiangsu, China
Collaborators
Shanghai Shape Memory Alloy Co., Ltd.
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03941691 on ClinicalTrials.govOther trials for Rare congenital anomaly of ventricular septum
Additional recruiting or active studies for the same condition.
See all trials for Rare congenital anomaly of ventricular septum →